[Federal Register Volume 87, Number 195 (Tuesday, October 11, 2022)]
[Notices]
[Pages 61326-61327]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22028]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-22GG]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Pilot Plan for the Interim Local Health 
Department Strategy for Response, Control, and Prevention of Healthcare 
Associated Infections (HAI) and Antibiotic Resistance (AR)'' to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection

[[Page 61327]]

Submitted for Public Comment and Recommendations'' notice on June 17th, 
2022 to obtain comments from the public and affected agencies. CDC did 
not receive comments related to the previous notice. This notice serves 
to allow an additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Pilot Plan for the Interim Local Health Department Strategy for 
Response, Control, and Prevention of Healthcare Associated Infections 
(HAI) and Antibiotic Resistance (AR)--New--National Center for Emerging 
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    Through piloting the Interim Local Strategy, CDC's Division of 
Healthcare Quality Promotion (DHQP) aims to understand Local Health 
Departments' (LHDs) experience implementing the strategy and collect 
their feedback for refinement. A secondary goal of this study is to 
create a network of LHDs working in Healthcare Associated Infections 
(HAI) and Antibiotic Resistance (AR) activities to learn from one 
another and share best practices. Data collected during the pilot will 
be used to assess the extent to which the strategy materials and 
resources help LHDs to: (1) grow and expand their HAI/AR partner 
networks and collaboration; (2) build operational capacity to conduct 
and promote sustainable HAI/AR infection prevention and control 
practices; and (3) expand HAI/AR infection prevention, outbreak 
response, and stewardship activities. Furthermore, data will inform any 
necessary refinements of the materials and resources.
    CDC will conduct data collection through interviews and electronic 
surveys, to capture feedback on the strategy's usability and 
effectiveness, as well as on each individual material and resource. CDC 
will use a mixed methods approach with both deductive and inductive 
analysis of qualitative data collected through surveys and structured 
interviews, and aggregate quantitative survey data.
    CDC requests OMB approval for an estimated 360 annualized burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Voluntary LHD Participants/NACCHO Coag  LHD HAI/AR Strategy                   60               1               4
 LHD participants.                       Pilot Feedback Form.
Voluntary LHD Participants............  LHD HAI/AR Strategy                   30               1               2
                                         Pilot Interview Guide.
NACCHO CoAg LHD Participants..........  LHD HAI/AR Strategy                   30               1               2
                                         Pilot Survey.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-22028 Filed 10-7-22; 8:45 am]
BILLING CODE 4163-18-P